The clinical use of blood and blood products is appropriate, and strategies are used to reduce the risks associated with transfusion.
National Safety and Quality Health Service (NSQHS)
In this section are resources to assist health services address the actions in this criterion, which are:
- Optimising and conserving a patient’s own blood - information can be found in the section marked patient blood management - 7.4
- Documenting - 7.5
- Prescribing and administering blood and blood products - 7.6
- Reporting adverse events - 7.7 and 7.8.
Optimising and conserving patient’s own blood 7.4
- The examples of charts, checklists and forms relating to the administration of blood products are used to promote complete transfusion documentation.
- These can assist health services to support processes for prescribing and clinical use of blood and blood products.
Resources available include:
- a comprehensive form developed by Austin Health. It is an example of a form used for blood and blood product prescription and administration, consent documentation and adverse reaction reporting as well as providing guidance on blood administration safety, and the pre-transfusion checking requirements.
Prescribing and administering blood and blood products 7.6
Useful resources include:
- The is a comprehensive resource to assist with safe bedside transfusion practice. Australian Red Cross Lifeblood.
- - these posters are designed to assist health services with best-practice for blood administration.
- - the posters and swing tags can be used to demonstrate how to safely and effectively spike a blood component bag for administration.
- Australian Red Cross Lifeblood (7.6, 7.7 and 7.8) - the website provides information for clinicians on a range of blood related topics.
- The Australian and New Zealand Society of Blood Transfusion (ANZSBT) and the Royal Australian College of Physicians (RACP) have developed a . This is useful guidance for clinical transfusion practice.
- Prophylactic use of RhD immunoglobulin for RhD negative women: RhD immunoglobulin administered to pregnant RhD negative women can help prevent haemolytic disease of the fetus and newborn.
- To promote best practice and the provision of relevant information Blood Matters has developed the infographic:
Reporting and adverse events 7.7 and 7.8
- The is a voluntary reporting, state based system for reporting serious blood management and transfusion practice errors and transfusion reactions.
- (7.7 and 7.8) - a flowchart developed by Eastern Health showing the required management of suspected acute transfusion reactions.
- - (7.7 and 7.8) - a flowchart developed by Eastern Health showing the required management of suspected delayed transfusion reactions.
- (7.5, 7.7 and 7.8) - developed at RMH for reporting transfusion reactions to the Transfusion Laboratory and includes the order for subsequent blood testing. This form is now only used when the EMR is not available.
- (7.6) - the blood component compatibility report used at St Vincent’s Health, contains details of the compatibility of the blood component (the form is blank), and on the reverse side it has the blood checking requirements and a summary of possible adverse reactions. This is an example of the form that is sent with the unit of blood, blood product.
- (7.7 and 7.8) - a flowchart developed by Western Health showing the management of suspected acute blood, blood product reactions in adults.
- (7.7 and 7.8) - a flowchart developed by Western Health showing the management of suspected delayed blood, blood product reactions in adults.
- (7.7 and 7.8) - the form was developed by Western Health to report suspected transfusion reactions for investigation.
Reviewed 22 February 2023